Literature DB >> 22404973

Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin.

Eleazar Vega-Saenz de Miera, Erica B Friedman, Holly S Greenwald, Mary A Perle, Iman Osman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22404973      PMCID： PMC3329580          DOI： 10.1111/j.1755-148X.2012.00994.x

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  10 in total

Review 1.  Nestin expression--a property of multi-lineage progenitor cells?

Authors:  C Wiese; A Rolletschek; G Kania; P Blyszczuk; K V Tarasov; Y Tarasova; R P Wersto; K R Boheler; A M Wobus
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

2.  Differentiation and the tumorigenic and metastatic phenotype of murine melanoma cells.

Authors:  K Kameyama; W D Vieira; K Tsukamoto; L W Law; V J Hearing
Journal:  Int J Cancer       Date:  1990-06-15       Impact factor: 7.396

Review 3.  Molecular abnormalities in lung cancer.

Authors:  R Salgia; A T Skarin
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

4.  Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research.

Authors:  Lindsay G Wich; Heather K Hamilton; Richard L Shapiro; Anna Pavlick; Russell S Berman; David Polsky; Judith D Goldberg; Eva Hernando; Prashiela Manga; Michelle Krogsgaard; Hideko Kamino; Farbod Darvishian; Peng Lee; Seth J Orlow; Harry Ostrer; Nina Bhardwaj; Iman Osman
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

5.  CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.

Authors:  Joni L Rutter; Alisa M Goldstein; Michael R Dávila; Margaret A Tucker; Jeffery P Struewing
Journal:  Oncogene       Date:  2003-07-10       Impact factor: 9.867

6.  Germline splicing mutations of CDKN2A predispose to melanoma.

Authors:  Joanne C Y Loo; Ling Liu; AiHua Hao; LuZhuang Gao; Ron Agatep; Michael Shennan; Anne Summers; Alisa M Goldstein; Margaret A Tucker; Carolyn Deters; Ramon Fusaro; Kathleen Blazer; Jeffrey Weitzel; Norman Lassam; Henry Lynch; David Hogg
Journal:  Oncogene       Date:  2003-09-25       Impact factor: 9.867

7.  Nonrandom chromosome changes in malignant melanoma.

Authors:  R Becher; Z Gibas; C Karakousis; A A Sandberg
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

8.  Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.

Authors:  A P Albino; G Sozzi; D M Nanus; S C Jhanwar; A N Houghton
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

9.  Dissecting karyotypic patterns in malignant melanomas: temporal clustering of losses and gains in melanoma karyotypic evolution.

Authors:  Mattias Höglund; David Gisselsson; Gunnar B Hansen; Valerie A White; Torbjörn Säll; Felix Mitelman; Douglas Horsman
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

10.  Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.

Authors:  D Schadendorf; I Fichtner; A Makki; S Alijagic; M Küpper; U Mrowietz; B M Henz
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640
  10 in total
  7 in total

1.  Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in Melanoma.

Authors:  Keith M Giles; Brooke E Rosenbaum; Marlies Berger; Allison Izsak; Yang Li; Irineu Illa Bochaca; Eleazar Vega-Saenz de Miera; Jinhua Wang; Farbod Darvishian; Hua Zhong; Iman Osman
Journal:  J Invest Dermatol       Date:  2018-08-24       Impact factor: 8.551

2.  Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene.

Authors:  Barbara Fontanals-Cirera; Dan Hasson; Chiara Vardabasso; Raffaella Di Micco; Praveen Agrawal; Asif Chowdhury; Madeleine Gantz; Ana de Pablos-Aragoneses; Ari Morgenstern; Pamela Wu; Dan Filipescu; David Valle-Garcia; Farbod Darvishian; Jae-Seok Roe; Michael A Davies; Christopher R Vakoc; Eva Hernando; Emily Bernstein
Journal:  Mol Cell       Date:  2017-11-16       Impact factor: 17.970

3.  Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis.

Authors:  Douglas Hanniford; Alejandro Ulloa-Morales; Alcida Karz; Maria Gabriela Berzoti-Coelho; Rana S Moubarak; Beatriz Sánchez-Sendra; Andreas Kloetgen; Veronica Davalos; Jochen Imig; Pamela Wu; Varshini Vasudevaraja; Diana Argibay; Karin Lilja; Tommaso Tabaglio; Carlos Monteagudo; Ernesto Guccione; Aristotelis Tsirigos; Iman Osman; Iannis Aifantis; Eva Hernando
Journal:  Cancer Cell       Date:  2020-01-13       Impact factor: 31.743

4.  Melanoma-Secreted Amyloid Beta Suppresses Neuroinflammation and Promotes Brain Metastasis.

Authors:  Kevin Kleffman; Grace Levinson; Indigo V L Rose; Lili M Blumenberg; Sorin A A Shadaloey; Avantika Dhabaria; Eitan Wong; Francisco Galán-Echevarría; Alcida Karz; Diana Argibay; Richard Von Itter; Alfredo Floristán; Gillian Baptiste; Nicole M Eskow; James A Tranos; Jenny Chen; Eleazar C Vega Y Saenz de Miera; Melissa Call; Robert Rogers; George Jour; Youssef Zaim Wadghiri; Iman Osman; Yue-Ming Li; Paul Mathews; Ronald B DeMattos; Beatrix Ueberheide; Kelly V Ruggles; Shane A Liddelow; Robert J Schneider; Eva Hernando
Journal:  Cancer Discov       Date:  2022-05-02       Impact factor: 38.272

5.  Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.

Authors:  Ines P Silva; Amel Salhi; Keith M Giles; Matjaz Vogelsang; Sung W Han; Naima Ismaili; Kevin P Lui; Eric M Robinson; Melissa A Wilson; Richard L Shapiro; Anna Pavlick; Judy Zhong; Tomas Kirchhoff; Iman Osman
Journal:  Clin Cancer Res       Date:  2015-12-02       Impact factor: 12.531

6.  Functional analysis of RPS27 mutations and expression in melanoma.

Authors:  Alfredo Floristán; Leah Morales; Douglas Hanniford; Carlos Martinez; Elena Castellano-Sanz; Igor Dolgalev; Alejandro Ulloa-Morales; Eleazar Vega-Saenz de Miera; Una Moran; Farbod Darvishian; Iman Osman; Tomas Kirchhoff; Eva Hernando
Journal:  Pigment Cell Melanoma Res       Date:  2019-11-22       Impact factor: 4.693

7.  Selective lentiviral gene delivery to CD133-expressing human glioblastoma stem cells.

Authors:  N Sumru Bayin; Aram S Modrek; August Dietrich; Jonathan Lebowitz; Tobias Abel; Hae-Ri Song; Markus Schober; David Zagzag; Christian J Buchholz; Moses V Chao; Dimitris G Placantonakis
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.